Phadia launches Phadia 2500 and 5000 Phadia: a growing variety of solutions for diagnostics of allergies and diseases autoimmune.
-instruments of great capacity, that combine evidence of allergies and autoimmune diseases, and based on the proven technology of Phadia for reliability
Uppsala, Sweden, August 23, 2011- / PRNewswire / – today Phadia, global leader in diagnostics of allergies and autoimmune diseases, announced the launch of the new instruments of Phadia for allergies and autoimmune diseases tests: Phadia 2500 and 5000 Phadia.
The new instruments of great capacity offer the possibility of combining evidence of allergies and autoimmune diseases, which means one performance 4 to 5 times greater than that of any other instrument combined available to today. With 2500 Phadia, laboratories can offer up 25,000 results per week and up to 50,000 results using Phadia 5000. Both instruments are flexible, with the possibility of analyzing more than 360 allergens and 80 components allergenic, in combination with a panel of antigens for autoimmune diseases, optimized to evaluate more than 20 autoimmune diseases. For high productivity, better support and assistance for the resolution of problems, can connect instruments to Lab Community (community laboratory), which is the system of monitoring of Phadia remote insurance.
“Phadia 2500 and 5000 Phadia provide flexibility, high capacity and reliability”. “They are based on proven technology and are well equipped to satisfy large volumes of demand for clinical laboratories to waiting times shorter, higher performance and efficiency,” said Peter Silfwerbrand, Executive Vice President.
The new instruments of great capacity based on the same technology employed in the family of Phadia Laboratory Systems (Phadia laboratory systems) products, including Phadia 100, Phadia 250 and 1000 Phadia. Grouping and combining various instruments within the Phadia Laboratory Systems provides a number of exclusive advantages, that used the same software on all computers, including managing the results of the tests with Phadia Information Data Manager (Administrator Phadia data information), which is easy to use and intuitive, or evaluate the quality by means of the largest in the world of quality assessment program, Phadia Quality Club (Phadia quality Club), which is optional. In order to increase efficiency, the instruments can connect to a Laboratory Automation System (laboratory automation system) to handle and transport tubes of samples.
With the launch today, Phadia offers a full range of tools and components to diagnose allergies and autoimmune diseases; which meets the demands of clinical laboratories around the world, from the smallest to the largest.
About Phadia
Phadia develops, manufactures and markets blood test complete systems to support clinical diagnosis and controlling allergies, asthma and autoimmune diseases. Our mission is to substantially improve the management of allergy, asthma and autoimmune diseases, health professionals offering diagnostic technologies superiors and clinical expertise. We provide more than seven of ten laboratory tests to diagnose allergies around the world; and four of ten tests of autoimmune diseases to laboratories across Europe.
